Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

MLAB Insider Trading

MESA LABORATORIES INC /CO/ | Industrial Instruments For Measurement, Display, and Control

Comprehensive Trading Performance Summary

The investment history of corporate insiders at MESA LABORATORIES INC /CO/ provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Industrial Instruments For Measurement, Display, and Control sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2021-07-19 16:17 2021-07-16 GUILLEMIN EVAN Director SELL $282.18 720 $203,170 29,450 -2.4%
2021-07-13 19:02 2021-07-12 Sakys John Officer - CFO OPT+S $278.77 1,000 $278,770 7,514 0.0%
2021-07-06 17:48 2021-07-01 Sullivan John James Director SELL $267.44 1,250 $334,300 24,299 -4.9%
2021-07-06 23:11 2021-07-01 Sakys John Officer - CFO OPT+S $267.04 1,000 $267,040 7,514 0.0%
2021-06-21 17:21 2021-06-17 Archbold Brian David Officer - SVP Continuous Improvement SELL $256.56 400 $102,624 793 -33.5%
2021-06-17 19:06 2021-06-16 Archbold Brian David Officer - SVP Continuous Improvement SELL $257.06 1,336 $343,430 1,193 -52.8%
2021-06-17 19:25 2021-06-16 Owens Gary M Director, Officer - President and CEO SELL $255.67 6,545 $1,673,360 18,396 -26.2%
2021-06-17 20:01 2021-06-16 Schmieder John Bradley Director SELL $262.27 505 $132,446 71,507 -0.7%
2021-06-17 19:16 2021-06-16 DINOIA GREGORY Officer - SVP Commericial SELL $255.67 1,211 $309,616 2,973 -28.9%
2021-06-17 19:50 2021-06-16 Sakys John Officer - CFO SELL $255.67 2,119 $541,765 7,514 -22.0%
2021-06-17 01:40 2021-06-16 GUILLEMIN EVAN Director SELL $256.36 720 $184,579 30,170 -2.3%
2021-06-09 18:54 2021-06-08 Sullivan John James Director OPT+S $258.19 5,192 $1,340,522 24,208 0.0%
2021-06-08 18:12 2021-06-07 Owens Gary M Officer - President and CEO SELL $264.00 1,350 $356,400 8,513 -13.7%
2021-06-07 20:19 2021-06-04 DINOIA GREGORY Officer - SVP Commercial OPT+S $260.27 540 $140,546 840 0.0%
2021-06-08 01:34 2021-06-04 KELLY DAVID M Director OPT+S $260.28 851 $221,498 2,600 0.0%
2021-06-04 23:41 2021-06-01 Sullivan John James Director SELL $251.46 2,215 $556,984 24,208 -8.4%
2021-05-18 19:49 2021-05-17 GUILLEMIN EVAN Director SELL $244.25 720 $175,860 30,595 -2.3%
2021-05-07 18:20 2021-05-05 Sullivan John James Director SELL $250.23 300 $75,069 32,859 -0.9%
2021-05-06 01:04 2021-05-04 Sullivan John James Director SELL $250.14 735 $183,853 33,159 -2.2%
2021-04-19 17:52 2021-04-16 GUILLEMIN EVAN Director SELL $253.77 720 $182,714 31,315 -2.2%
2021-04-12 17:53 2021-04-05 Sullivan John James Director SELL $250.76 500 $125,380 33,894 -1.5%
2021-04-06 01:26 2021-04-05 Sullivan John James Director SELL $250.76 500 $125,380 57,458 -0.9%
2021-03-17 02:57 2021-03-16 GUILLEMIN EVAN Director SELL $269.48 720 $194,026 32,035 -2.2%
2021-03-15 16:50 2021-03-12 Sakys John Officer - CFO OPT+S $263.84 2,500 $659,600 4,350 0.0%
2021-03-11 18:24 2021-03-10 Archbold Brian David Officer - SVP Continuous Improvement OPT+S $271.78 223 $60,607 154 0.0%
2021-03-02 18:43 2021-03-01 Sullivan John James Director SELL $273.94 1,250 $342,425 57,958 -2.1%
2021-02-24 18:47 2021-02-23 DINOIA GREGORY Officer - SVP Commericial SELL $276.75 280 $77,490 840 -25.0%
2021-02-17 18:44 2021-02-16 GUILLEMIN EVAN Director SELL $281.52 3,600 $1,013,472 32,755 -9.9%
2021-02-11 03:24 2021-02-10 Schmieder John Bradley Director SELL $278.23 1,750 $486,903 71,717 -2.4%
2021-02-02 02:59 2021-02-01 Sullivan John James Director SELL $277.67 1,250 $347,088 59,208 -2.1%
2021-01-12 18:27 2021-01-12 Schmieder John Bradley Director SELL $285.23 477 $136,055 73,467 -0.6%
2021-01-07 19:40 2021-01-06 Sakys John Officer - CFO OPT+S $290.00 16 $4,640 3,350 0.0%
2021-01-05 01:14 2021-01-04 Sullivan John James Director SELL $280.82 1,250 $351,025 60,458 -2.0%
2020-12-14 19:57 2020-12-11 KELLY DAVID M Director SELL $283.18 250 $70,795 2,350 -9.6%
2020-12-02 03:36 2020-12-01 Sullivan John James Director SELL $275.22 1,250 $344,025 61,708 -2.0%
2020-11-18 20:40 2020-11-17 Sakys John Officer - CFO OPT+S $290.00 984 $285,360 3,350 0.0%
2020-11-18 19:09 2020-11-16 KELLY DAVID M Director OPT+S $283.31 704 $199,450 2,600 0.0%
2020-11-16 19:48 2020-11-13 GUILLEMIN EVAN Director OPT+S $274.30 2,050 $562,315 35,878 0.0%
2020-11-14 01:21 2020-11-12 GUILLEMIN EVAN Director OPT+S $273.77 950 $260,082 35,878 0.0%
2020-11-12 20:24 2020-11-11 Sullivan John James Director SELL $272.36 1,250 $340,450 62,481 -2.0%
2020-11-11 00:18 2020-11-09 Archbold Brian David Officer - SVP Continuous Improvement OPT+S $272.11 533 $145,035 232 0.0%
2020-10-10 01:20 2020-10-07 Owens Gary M Officer - President and CEO SELL $275.62 1,000 $275,617 9,863 -9.2%
2020-10-10 01:29 2020-10-08 Sakys John Officer - CFO OPT+S $276.90 942 $260,840 3,350 0.0%
2020-10-07 01:35 2020-10-06 Owens Gary M Officer - President and CEO SELL $265.00 1,000 $265,000 10,863 -8.4%
2020-10-06 03:01 2020-10-02 DINOIA GREGORY Officer - SVP Commercial OPT+S $260.00 332 $86,320 1,120 0.0%
2020-09-17 23:31 2020-09-16 Owens Gary M Officer - President and CEO OPT+S $249.32 100 $24,932 11,863 0.0%
2020-09-08 19:08 2020-09-04 DINOIA GREGORY Officer - SVP Commerical SELL $243.55 280 $68,194 1,182 -19.2%
2020-09-04 18:25 2020-09-01 Sakys John Officer - CFO OPT+S $251.00 1,000 $250,997 3,400 0.0%
2020-09-02 23:41 2020-08-28 KELLY DAVID M Director OPT+S $244.77 780 $190,920 2,810 0.0%
2020-08-19 00:20 2020-08-17 DINOIA GREGORY Officer - SVP Commercial OPT+S $245.70 835 $205,160 1,462 0.0%
SHOW ENTRIES

How to Interpret $MLAB Trades

Not every insider transaction in MESA LABORATORIES INC /CO/ is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MLAB shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for MLAB

Insider activity data for MESA LABORATORIES INC /CO/ is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MLAB, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.